Bystander activation, i.e., activation of T cells specific for an antigen X during an immune response against antigen Y may occur during viral infections. However, the low frequency of bystander-activated T cells has rendered it difficult to define the mechanisms and possible in vivo relevance of this nonspecific activation. This study uses transgenic mice expressing a major histocompatibility complex class I–restricted TCR specific for glycoprotein peptide 33-41 of lymphocytic choriomeningitis virus (LCMV) to overcome this limitation. CD8+ T cells from specific pathogen-free maintained, unimmunized “naive” TCR transgenic mice can differentiate into LCMV-specific cytolytic effector CTL during infections with vaccinia virus or Listeria monocytogenes in vivo or mixed lymphocyte culture in vitro. We show that in these model situations (a) nonspecifically activated CTL are able to confer antiviral protection in vivo, (b) bystander activation is largely independent of the expression of a second T cell receptor of different specificity, (c) bystander activation is not mediated by a broadly cross-reactive TCR, but rather by cytokines, (d) bystander activation can be mediated by cytokines such as IL-2, but not α/β-IFN in vitro; (e) bystander activation is, overall, a rare event, occuring in vivo in roughly 1 in 200 of the LCMV-specific CTL during infection of TCR transgenic mice with vaccinia virus; (f) bystander activation does not have a significant functional impact on nontransgenic CTL memory under the conditions tested; and (g) even in the TCR transgenic situation, where unphysiologically high numbers of T cells of a single specificity are present, bystander activation is not sufficient to cause clinically manifest autoimmune disease in a transgenic mouse model of diabetes. We conclude that although bystander activation via cytokines may generate cytolytically active CTL from naive precursors, quantitative considerations suggest that this is usually not of major biological consequence.
Skip Nav Destination
Article navigation
7 April 1997
Article|
April 07 1997
Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model
Stephan Ehl,
Stephan Ehl
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Joachim Hombach,
Joachim Hombach
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Peter Aichele,
Peter Aichele
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Hans Hengartner,
Hans Hengartner
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Rolf M. Zinkernagel
Rolf M. Zinkernagel
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Stephan Ehl
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Joachim Hombach
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Peter Aichele
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Hans Hengartner
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Rolf M. Zinkernagel
From the Institute of Experimental Immunology, Department of Pathology, University of Zürich, CH-8091 Zürich, Switzerland
Address correspondence to Dr. Stephan Ehl, Institute of Experimental Immunology, Department of Pathology, University of Zürich, Schmelzbergstr. 12, CH-8091 Zürich, Switzerland.
S. Ehl and J. Hombach have contributed equally to this work.
1Abbreviations used in this paper: gp33, glycoprotein 33-41; LCMV, lymphocytic choriomeningitis virus; RIP, rat insulin promotor; SPF, specific pathogen-free.
Received:
November 18 1996
Revision Received:
January 27 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (7): 1241–1252.
Article history
Received:
November 18 1996
Revision Received:
January 27 1997
Citation
Stephan Ehl, Joachim Hombach, Peter Aichele, Hans Hengartner, Rolf M. Zinkernagel; Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model. J Exp Med 7 April 1997; 185 (7): 1241–1252. doi: https://doi.org/10.1084/jem.185.7.1241
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement